CBD: Alzheimer's





Footnotes

1 - Liu, C.S., Chau, S.A. Ruthirikuhan, M et al. "Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease," CSN Drugs (August 2015).

2 - "Alzheimer's Disease Fact Sheet" National Institute on Aging (www.nia.nih.gov).

3 - "Alzheimer's Disease Fact Sheet" National Institute on Aging (www.nia.nih.gov).

4 - "About Alzheimer's Disease: Alzheimer's Basics," National Institute on Aging (www.nia.nih.gov)

5 - "Treatment Horizon," Alzheimer's Association, alz.org/research.

6 - Liu, C.S., Chau, S.A. Ruthirikuhan, M et al. "Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease," CSN Drugs (August 2015).

7 - Eubanks, L, Rogers, C, Beuscher, A et al. "A Molecular Link Between the Active Component in CBD and Alzheimer's Disease Pathology," National Institutes of Health (Oct 6, 2008).

8 - Eubanks, L, Rogers, C, Beuscher, A et al. "A Molecular Link Between the Active Component in CBD and Alzheimer's Disease Pathology," National Institutes of Health (Oct 6, 2008).

9 - Eubanks, L, Rogers, C, Beuscher, A et al. "A Molecular Link Between the Active Component in CBD and Alzheimer's Disease Pathology," National Institutes of Health (Oct 6, 2008).

10 - "CBD, A Better and Safer Treatment Option for Alzheimer's," www.solcbd.com.

11 - Aso, E, and Ferrer, I. "Cannabinoids for Treatment of Alzheimer's disease: Moving Toward the Clinic," U.S. National Library of Medicine (March 5, 2014).

12 - Shelef, A, Barak, Y, et al. "Safety and Efficacy of Medical CBD for Behavioral and Psychological Symptoms of Dementia" U.S. National Library of Medicine (2016).

Nutra Pure LLC BBB Business Review